The recent surge in investments into boutique pharmaceutical companies, particularly those focusing on novel therapies and difficult drug development programs, has fueled what some are calling "High Roller Pharma." https://imogenibkj624267.oblogation.com/39047811/high-investor-pharma-the-risky-wager